Pathology of Clostridium Difficile

1274 Words3 Pages

Description of Clostridium Difficile Clostridium difficile, otherwise known as C. diff, is a species of spore-forming, anaerobic, gram-positive bacteria that is known to cause watery diarrhea. 1 The genus name, Clostridium refers to the spindle shape of the organism while Difficile means difficult in Latin due to the fact that this organism thrives in unfavorable conditions and is very difficult to isolate.4 The incidence of getting CDI has increased over the years due to new strains of increased toxin production of the bacteria and increased resistance to antibiotics.2 It is a gastrointestinal infection, and the most common cause of infectious diarrhea.1 C. difficile was first identified in the feces of healthy newborns back in the 1930’s and by 1935, it was considered normal flora. 2 During 1974, researchers conducted that about 21% of patients that were treated with an antibiotic called clindamyacin reported diarrhea and about 10% of them reported to have conducted pseudomembranous colitis as a side effect of this treatment. 2 It was in 1978 where C. diff had been known to cause anti-biotic associated diarrhea and pseudomembranous colitis. 2 It is known to form spores that resist many disinfectants; it also survives for several months on different surfaces.1 It is a common form of a nosocomial infection and the prevalence of becoming infected with C. diff is about 0-15% in a health care setting. 3 The spores survive well in environments such as soil, water and animals and is distributed worldwide. 4 CDI produces two toxins (Toxin A and B), which are cytotoxic and cause tissue necrosis.4 Transmission C. difficile is highly contagious and is transmitted through the fecal-oral route. 2 It also known to develop right afte... ... middle of paper ... ...ns should be worn. 2 Vaccines and Antisera Currently, there is no official vaccine that is being used to protect patients against C. diff. Vaccines are currently being developed which targets the specific proteins of the organism that is essential for vaccine development. 5 These proteins produce an immune response when introduced to a host. 5 There are also recent clinical trials that have shown strains of C. diff that only produce toxin B exist and that developing an antitoxin B may be used in defense of an infection. 5 Researchers have also developed vaccine that contains purified versions of toxin A and B. Patients injected with this vaccine had a significant rise of antitoxins during the 30th day of the vaccination regimen. Although this vaccine did not create any adverse reaction and was deemed safe by the researchers it is still under clinical trial. 5

Open Document